Efficacy of D‐cycloserine augmented brief intensive cognitive‐behavioural therapy for paediatric obsessive‐compulsive disorder: A randomised clinical trial

OBJECTIVE: To examine the efficacy of weight‐adjusted D‐cycloserine (DCS) (35 or 70 mg) relative to placebo augmentation of intensive exposure therapy for youth with obsessive‐compulsive disorder (OCD) in a double‐blind, randomised controlled trial, and examine whether antidepressant medication or p...

Descripción completa

Detalles Bibliográficos
Autores principales: Farrell, Lara J., Waters, Allison M., Tiralongo, Evelin, Mathieu, Sharna, McKenzie, Matthew, Garbharran, Vinay, Ware, Robert S., Zimmer‐Gembeck, Melanie J., McConnell, Harry, Lavell, Cassie, Cadman, Jacinda, Ollendick, Thomas H., Hudson, Jennifer L., Rapee, Ronald M., McDermott, Brett, Geller, Daniel, Storch, Eric A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9303435/
https://www.ncbi.nlm.nih.gov/pubmed/35084071
http://dx.doi.org/10.1002/da.23242

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9303435/
https://www.ncbi.nlm.nih.gov/pubmed/35084071
http://dx.doi.org/10.1002/da.23242

Ejemplares similares